Product Stewardship Dashboard

Monitoring: Depigmenting Brightening Serum (18-65 Indian Adults)

+12%

Total Enrolled

1,284

Avg Irritation

0.42

Out of 3.0

+3%

Sunscreen Adherence

91%

Efficacy Score

8.4/10

Patient reported

8-Week Monitoring Performance

Improvement %

Irritation Grade

System Notifications

Warning Reviewing

Batch B-102 (Fragrance) reporting 2.1% mild irritation.

Critical Action Required

Patient ID #442: Severe erythema reported. Automated hold triggered.

Info Resolved

85% of users report improved texture at Week 4.

Clinician Intelligence Summary

This serum combines alpha-arbutin, kojic acid, and vitamin C for cosmetic-grade brightening of melasma-associated dark spots. Monitor for contact-dermatitis type irritation, especially in those with propylene glycol/fragrance allergy. Advise 8-week monitoring of dark-spot appearance and adherence to daily broad-spectrum sunscreen.

Adults 18-65 Non-Inflammatory Melasma Pregnancy Caution

Evidence Ranking

Depigmenting (A-Arbutin) 90% Match

Antioxidants (Silymarin) 75% Match

Barrier (Glycerin) 60% Match

Ingredient Clinical Matrix

Evidence levels and human-data correlation based on literature mining.

Active Ingredient	Target Pathway	Evidence Level	Primary Source	Action

User Adherence Breakdown

Percentage of users recording daily sunscreen application.